open access

Vol 86, No 6 (2015)
ARTICLES
Get Citation

Efficacy and tolerability of intravenous morphine patient-controlled analgesia (PCA) in women undergoing cesarean delivery

Marta Andziak, Jarosław Beta, Michał Barwijuk, Tadeusz Issat, Artur J. Jakimiuk
DOI: 10.17772/gp/2403
·
Ginekol Pol 2015;86(6).

open access

Vol 86, No 6 (2015)
ARTICLES

Abstract

Objectives: The aim of the study was to evaluate analgesic efficacy and tolerability of patient-controlled analgesia (PCA) with intravenous morphine. Material and methods: Our observational study included 50 women who underwent a Misgav-Ladach or modified Misgav-Ladach cesarean section. Automated PCA infusion device (Medima S-PCA Syringe Pump, Medima, Krakow, Poland) was used for postoperative pain control. Time of morphine administration or initiation of intravenous patient-controlled analgesia (IV PCA) with morphine was recorded, as well as post-operative pain at rest assessed by a visual analogue scale (VAS). All patients were followed up for 24 hours after discharge from the operating room, taking into account patient records, worst pain score at rest, number of IV PCA attempts, and drug consumption. Results: Median of total morphine doses used during the postoperative period was 42.9mg (IQR 35.6–48.5), with median infusion time of 687.0 min. (IQR 531.0–757.5). Pain severity and total drug consumption improved after the first 3 hours following cesarean delivery (p<0.01). Mean number of PCA attempts per patient was 33 (IQR: 24–37), with median of 11 placebo attempts (IQR: 3–27). Conclusions: Patient-controlled analgesia with morphine is an efficient and acceptable analgesic method in women undergoing cesarean section.

Abstract

Objectives: The aim of the study was to evaluate analgesic efficacy and tolerability of patient-controlled analgesia (PCA) with intravenous morphine. Material and methods: Our observational study included 50 women who underwent a Misgav-Ladach or modified Misgav-Ladach cesarean section. Automated PCA infusion device (Medima S-PCA Syringe Pump, Medima, Krakow, Poland) was used for postoperative pain control. Time of morphine administration or initiation of intravenous patient-controlled analgesia (IV PCA) with morphine was recorded, as well as post-operative pain at rest assessed by a visual analogue scale (VAS). All patients were followed up for 24 hours after discharge from the operating room, taking into account patient records, worst pain score at rest, number of IV PCA attempts, and drug consumption. Results: Median of total morphine doses used during the postoperative period was 42.9mg (IQR 35.6–48.5), with median infusion time of 687.0 min. (IQR 531.0–757.5). Pain severity and total drug consumption improved after the first 3 hours following cesarean delivery (p<0.01). Mean number of PCA attempts per patient was 33 (IQR: 24–37), with median of 11 placebo attempts (IQR: 3–27). Conclusions: Patient-controlled analgesia with morphine is an efficient and acceptable analgesic method in women undergoing cesarean section.
Get Citation

Keywords

patient-controlled analgesia / PCA / intravenous morphine / cesarean section /

About this article
Title

Efficacy and tolerability of intravenous morphine patient-controlled analgesia (PCA) in women undergoing cesarean delivery

Journal

Ginekologia Polska

Issue

Vol 86, No 6 (2015)

DOI

10.17772/gp/2403

Bibliographic record

Ginekol Pol 2015;86(6).

Keywords

patient-controlled analgesia / PCA / intravenous morphine / cesarean section /

Authors

Marta Andziak
Jarosław Beta
Michał Barwijuk
Tadeusz Issat
Artur J. Jakimiuk

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl